Successful Management of Severe Intraperitoneal Hemorrhage by Platelet Transfusion in a Patient with Acquired Factor V Inhibitor
スポンサーリンク
概要
著者
-
WADA Hideho
Division of Hematology, Department of Medicine, Kawasaki Medical School
-
NAKANISHI Hidekazu
Division of Hematology,Department of Medicine, Kawasaki Medical School
-
YATA Kenichiro
Division of Hematology, Department of Medicine, Kawasaki Medical School
-
Wada H
Division Of Hematology Department Of Medicine Kawasaki Medical School
-
Wada Hideho
Division Of Hematology Department Of Medicine Kawasaki Medical School
-
Wada Hideho
Hematology Kawasaki Medical School
-
Yata K
Division Of Hematology Department Of Medicine Kawasaki Medical School
-
Nishimura Hirotake
Division Of Hematology Department Of Medicine Kawasaki Medical School
-
Nishimura Hirotake
Kawasaki Medical School Kurashiki Jpn
-
Nakanishi Hidekazu
Division Of Hematology Department Of Medicine Kawasaki Medical School
-
Yata Ken-ichiro
Department Of Medicine And Bioregulatory Sciences University Of Tokushima Graduate School Of Medicin
関連論文
- A Peculiar Case of Acute Myeloid Leukemia Mimicking Plasmacytoid Dendritic Precursor Cell Leukemia
- Pure Red Cell Aplasia and Myasthenia Gravis with Recurrent Thymoma
- Primary adrenal lymphoma discovered as an incidentaloma: case report and review of the literature
- Low-dose Total Body Irradiation in the Treatment of Advanced Non-Hodgkin's Lymphoma : A Case Report of an Elderly Patient
- Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma
- CA125 and CA15-3 Tumor Markers are Closely Associated with Disease Activity in a Patient with Diffuse Large B-cell Lymphoma
- Monocyte/Macrophage-Specific Marker CD163^+ Histiocytic Sarcoma : Case Report with Clinical, Morphologic, Immunohistochemical, and Molecular Genetic Studies
- Multiple Myeloma Complicated by Autoimmune Hemolytic Anemia
- Immunohistochemical assessment of human bone marrow macrophages in hematologic disorders
- Expression of cytotoxic molecule TIA-1 in malignant lymphomas mimicking fulminant hepatitis
- Epstein-Barr virus-associated Hodgkin's disease in HTLV-I seropositive patients : A report of two cases
- Cell biological roles of IL-10 in myeloma cells
- Cellular Biological Differnces Between Human Myeloma Cell Lines KMS-12-PE and KMS-12-BM Established From a Single Patient
- Band 4.2 Komatsu: 523 GAT → TAT (175 Asp → Tyr) in exon 4 of the band 4.2 gane associated with total deficiency of band 4.2, hemolytic anemia with ovalostomatocytosis and marked disruption of the cytoskeletal network
- Relationships between DNA Methylation and Expression in Erythrocyte Membrane Protein (Band 3, Protein 4.2, and β-Spectrin) Genes during Human Erythroid Development and Differentiation
- DNA Methylation in Promoter Regions of Red Cell Membrane Protein Genes in Healthy Individuals and Patients with Hereditary Membrane Disorders
- Ankyrin Gene Mutations in Japanese Patients With Hereditary Spherocytosis
- Synergistic Growth Inhibition of YM529 with Biologic Response Modifiers (BRMs) in Myeloma Cells
- Ph clone recurrence after imatinib discontinuation for chronic myelogenous leukemia patients who had complete molecular remission.
- MLL/AF-1p Fusion in Therapy-Related Early Pre-B Acute Lymphoblastic Leukemia with t(1;11)(p32;q23) Translocation Developing in the Relapse Phase of Acute Promyelocytic Leukemia
- Multiple Myeloma Associated with Thrombocytopenia Caused by Immunological Destruction
- Transformation from follicular lymphoma to high-grade B-cell lymphoma/leukemia with additional t(2;8)(p12;q24), with inverse expressions of c-MYC and BCL-2, and light-chain switch
- Small cell variant of anaplastic large cell lymphoma diagnosed by a novel chromosomal abnormality t(2;5;3)(p23;q35;p21) of bone marrow cells
- Successful Management of Severe Intraperitoneal Hemorrhage by Platelet Transfusion in a Patient with Acquired Factor V Inhibitor
- The impact of serum soluble interleukin-2 receptor levels on the diagnosis of malignant lymphoma
- Expression of Angiogenic Factors in Myeloma Cells
- Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells